LifeStance price target lowered to $6 from $8 at Barclays

Barclays lowered the firm’s price target on LifeStance to $6 from $8 and keeps an Underweight rating on the shares. The company’s Q2 print that featured a headline beat and more moderated fiscal 2024 guidance raise versus the revenue and EBITDA upside in the quarter, the analyst tells investors in a research note. The firm says LifeStance shares continue to trade at a meaningful premium to peers.